Amalus Therapeutics (Private limited company)
Amalus Therapeutics is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0803.929.268. It was founded on 13-07-2023. Its registered office is in Ghent. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2024 report equity of € -331 736 and a loss of € 341 736. These accounts report 1.6 full-time equivalents.
Information last updated on 07-10-2026.
Company information
Key figures of Amalus Therapeutics
| 2024 | |
|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -341 736 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € -331 736 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 160 051 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € 111 410 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | 1.6 |
Similar companies
Other companies in the same activity in Ghent.
| Company | Town |
|---|---|
| RNA Pioneering | 9052 Gent |
| Eurofins Amatsigroup | 9052 Gent |
| Taikun Pharmaceutical Technology | 9052 Gent |
| APCOR R&M | 9052 Gent |
| 272BIO | 9052 Gent |
| AVROXA | 9052 Gent |
| ILiAD Biotechnologies | 9052 Gent |
| AnimAb | 9052 Gent |
Frequently asked questions
Is Amalus Therapeutics still active? The Crossroads Bank for Enterprises records a bankruptcy procedure for Amalus Therapeutics.
What is the VAT number of Amalus Therapeutics? The VAT number of Amalus Therapeutics is BE 0803.929.268.
When was Amalus Therapeutics founded? Amalus Therapeutics was founded on 13-07-2023.
What is the address of Amalus Therapeutics? The current registered office of Amalus Therapeutics is Technologiepark-Zwijnaarde 82, 9052 Gand.
When did Amalus Therapeutics last file annual accounts? The latest annual accounts of Amalus Therapeutics were filed on 07-07-2025.
How many employees does Amalus Therapeutics have? Amalus Therapeutics employs 1.6 full-time equivalents according to its most recent annual accounts.
Is Amalus Therapeutics profitable? The annual accounts of Amalus Therapeutics for 2024 show a loss of € 341 736.
What is the equity of Amalus Therapeutics? The equity of Amalus Therapeutics was € -331 736 at the close of the 2024 financial year.
Who are the directors of Amalus Therapeutics? The annual accounts of Amalus Therapeutics record 3 mandates. The names, roles and dates are visible with a free account.
Can Amalus Therapeutics receive Peppol e-invoices? Yes. Amalus Therapeutics is registered on the Peppol network and can receive structured electronic invoices.
What does Amalus Therapeutics do? The main activity of Amalus Therapeutics is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.